Showing results (561-570 of 605) with videos related to

Sort By:
Pageof 61
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndromeMathias Sauer, Bárbara Fernandes Gomes, Parasto Shahrouki, et al.
The Lancet. Neurology|August 16, 2025
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisJoseph Therriault, Wagner S Brum, Lydia Trudel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
The Journal of Prevention of Alzheimer'S Disease|February 20, 2024
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE ProjectK Malzbender, P Barbarino, P Barkman Ferrell, et al.
Neurology|August 21, 2024
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical ResearchAndrei Bieger, Wagner S Brum, Wyllians V Borelli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 18, 2023
Operationalizing the centiloid scale for [18F]florbetapir PET studies on PET/MRIWilliam Coath, Marc Modat, M Jorge Cardoso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 10, 2025
Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's diseaseAdam P Mecca, Nicholas J Ashton, Ming-Kai Chen, et al.
Alzheimer'S Research & Therapy|November 3, 2023
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET studyIlse Bader, Ilona Bader, Isadora Lopes Alves, et al.
Pageof 61